Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]
Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial Cancer [clinicaltrials:NCT00003624]
Bio2RDF identifier
NCT00003624
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00003624
identifiers.org URI
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
RATIONALE: Drugs used i ...... erine, or endometrial cancer.
brief title [clinicaltrials_vocabulary:brief-title]
Amifostine in Treating Women W ...... Uterine, or Endometrial Cancer
collaborator [clinicaltrials_vocabulary:collaborator]
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
OBJECTIVES: I. Determin ...... dy within 18-36
months.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
1999-11-01T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
intervention browse [clinicaltrials_vocabulary:intervention-browse]
keyword [clinicaltrials_vocabulary:keyword]
endometrial adenocarcinoma
fallopian tube cancer
neurotoxicity
primary peritoneal cavity cancer
stage I cervical cancer
stage I endometrial carcinoma
stage I ovarian epithelial cancer
stage I uterine sarcoma
stage II cervical cancer
stage II endometrial carcinoma
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2013-04-10T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00003624
official title [clinicaltrials_vocabulary:official-title]
A Limited Access Trial Using A ...... clitaxel-Induced Neurotoxicity
org study id [clinicaltrials_vocabulary:org-study-id]
CDR0000066705
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
primary completion date [clinicaltrials_vocabulary:primary-completion-date]
2004-01-01T00:00:00Z
secondary id [clinicaltrials_vocabulary:secondary-id]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
1998-12-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2006-05-01T00:00:00Z
identifier
clinicaltrials:NCT00003624
title
Amifostine in Treating Women W ...... Uterine, or Endometrial Cancer
@en
type
label
Amifostine in Treating Women W ...... r [clinicaltrials:NCT00003624]
@en